--- title: "Glioblastoma Breakthrough Made by University Researchers" url: https://noti.group/glioblastoma-breakthrough-made-by-university-researchers/ language: en publisher: "Noti Group" section: "Health" published: 2026-11-01T10:49:13.000Z updated: 2026-11-01T17:30:22.149Z id: 231c49e1-37af-414b-871b-eb332f5ff02e source: "ScienceDaily Health https://www.sciencedaily.com/releases/2026/10/261030003017.htm" attribution: "Link to https://noti.group/glioblastoma-breakthrough-made-by-university-researchers/ and name Noti Group when you quote or summarize this story." --- # Glioblastoma Breakthrough Made by University Researchers A team led by Dr Roger Abounader has made a breakthrough in fighting glioblastoma, a highly aggressive form of brain cancer. Researchers at the University of Virginia's Comprehensive Cancer Center have made a breakthrough in the fight against glioblastoma, the most aggressive type of malignant brain tumor in adults. This devastating disease has proven resistant to existing treatments, but the new approach could change that. The team, led by Dr Roger Abounader, identified specific genetic molecules called microRNAs that can interfere with genes responsible for glioblastoma's growth and development. To deliver these molecules to the brain, the researchers combined cutting-edge technologies: specialized nanoparticles, focused ultrasound, and microscopic bubbles. This innovative combination enables the temporary crossing of the brain's protective barrier, which normally prevents many treatments from reaching brain tumors. By leveraging this approach, doctors may be able to target multiple cancer-promoting molecules simultaneously. Dr Abounader is optimistic about the potential of this new strategy, highlighting its ability to tackle a wide range of molecules that currently lack effective treatments. His team hopes to take their findings into clinical trials for patients with glioblastoma and other brain tumors in the future. Glioblastoma is a formidable foe in the world of oncology, accounting for more than 13,000 deaths annually in the United States alone. This highly aggressive form of brain cancer poses significant challenges to medical professionals due to its tendency to spread into surrounding healthy tissue, making it nearly impossible to remove entirely through surgery. The brain's natural defense mechanism, known as the blood-brain barrier, further complicates treatment efforts. This protective system safeguards the brain from toxins and infectious agents but unfortunately blocks many drugs that could potentially target cancer cells. As a result, glioblastoma remains exceptionally difficult to manage despite current treatments involving surgery, radiation therapy, and chemotherapy. These conventional approaches aim to remove as much of the tumor as possible through surgery, followed by radiation and chemotherapy to control remaining cancer cells and extend patient survival. However, this multi-faceted approach has its limitations, highlighting the need for innovative strategies in the fight against glioblastoma. Researchers are now exploring an alternative approach that leverages microRNAs, small pieces of genetic material capable of suppressing multiple problematic genes simultaneously. This novel strategy seeks to target and inhibit the activity of various cancer-related processes, offering a promising new direction in the battle against glioblastoma. The novel approach developed by researchers targets multiple genetic mechanisms involved in glioblastoma's growth and survival. This multi-pronged strategy has significant potential as it can help to slow or even halt tumor progression without the need for conventional cancer drugs. To deliver these therapeutic molecules to the brain, scientists are employing a unique method that leverages sound waves and magnetic resonance imaging (MRI) technology. Focused ultrasound is guided by MRI scans to precisely target the affected area, allowing researchers to direct the treatment with greater accuracy. The process involves using tiny "microbubbles in conjunction with ultrasound to temporarily open up the blood-brain barrier. This creates a brief window of opportunity for nanoparticles carrying microRNAs to pass through and enter the brain, where they can act on genes driving tumor growth. In laboratory experiments and animal models of glioblastoma, this approach has shown promising results. The treatment was found to slow down tumor growth and improve survival rates in animals with the disease. Further research is needed before this strategy can be tested in human patients. However, preliminary findings suggest that this technology may offer a new hope for individuals suffering from glioblastoma, as well as potentially other types of cancer. Researchers at UVA Health have been pioneers in harnessing the power of focused ultrasound for various medical conditions, including cancer treatment. Their extensive research program has explored how precisely directed sound waves can be used to target specific areas within the body with unprecedented precision. By leveraging this technology, scientists aim to develop novel approaches for treating a wide range of medical conditions beyond cancer. The Focused Ultrasound Immuno-Oncology (FUSION) Center is a collaborative effort between UVA Health and the Charlottesville-based Focused Ultrasound Foundation. This pioneering center focuses on investigating how combining focused ultrasound with cancer immunotherapy can revolutionize cancer treatment in the 21st century. This initiative also complements the broader missions of UVA Comprehensive Cancer Center and UVA's Paul and Diane Manning Institute of Biotechnology, both dedicated to driving new medical discoveries that improve patient care. UVA Comprehensive Cancer Center has earned a prestigious designation from the National Cancer Institute for its excellence in cancer research and patient care. This recognition places the center among an elite group of just 57 cancer centers nationwide that have received the comprehensive" designation. The Manning Institute plays a crucial role in advancing medical discoveries by speeding up the development of new medicines and potential cures for some of the most challenging diseases. Its work is supported by a statewide clinical trials network, which aims to make emerging treatments more accessible to patients as they move through research and testing phases. Abounader's team has published their experimental approach and initial laboratory findings in an open-access journal, making it freely available to readers. The study provides valuable insights into the researchers' innovative use of sound waves to target deadly brain cancer cells. The extensive research team involved in this project includes a diverse group of scientists with various areas of expertise, contributing to the comprehensive understanding of their experimental approach and its potential applications. Researchers have secured significant funding to support their groundbreaking approach to tackling deadly brain cancer using sound waves. The National Institutes of Health's National Cancer Institute and other organizations have provided substantial grants to aid in this research. The NIH's National Institute of Neurological Disorders and Stroke has also contributed funds, as well as the University of Virginia Comprehensive Cancer Center through a pilot grant. This extensive financial support from various institutions will undoubtedly play a crucial role in advancing the project's progress and potentially leading to significant breakthroughs in cancer treatment. --- Source: [ScienceDaily Health](https://www.sciencedaily.com/releases/2026/10/261030003017.htm) Published by Noti Group: https://noti.group/glioblastoma-breakthrough-made-by-university-researchers/